EphA1 Monoclonal Antibody

This gene belongs to the ephrin receptor subfamily of the protein-tyrosine kinase family. EPH and EPH-related receptors have been implicated in mediating developmental events, particularly in the nervous system. Receptors in the EPH subfamily typically have a single kinase domain and an extracellular region containing a Cys-rich domain and 2 fibronectin type III repeats. The ephrin receptors are divided into 2 groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands. This gene is expressed in some human cancer cell lines and has been implicated in carcinogenesis.

Introducing the EPHA1 Monoclonal Antibody, a cutting-edge biotechnological product designed to revolutionize the field of molecular research. This meticulously crafted antibody is specifically engineered to target and bind to the EPHA1 protein, a crucial component in cellular signaling pathways.

The EPHA1 Monoclonal Antibody boasts exceptional specificity and affinity, ensuring precise and reliable detection of EPHA1 protein expression in various biological samples. Its high sensitivity enables researchers to accurately quantify EPHA1 levels, facilitating comprehensive investigations into its functional role and potential implications in disease progression.

Crafted with utmost precision, this antibody undergoes rigorous quality control measures to guarantee optimal performance and reproducibility. Its exceptional stability and long shelf life ensure consistent results, making it an indispensable tool for both academic and industrial laboratories.

The EPHA1 Monoclonal Antibody's versatility extends beyond its primary application in research. Its potential for therapeutic use in targeted therapies and drug development is immense, as it holds promise in modulating EPHA1-mediated cellular processes. This antibody's potential to revolutionize the treatment landscape is truly remarkable.

In summary, the EPHA1 Monoclonal Antibody represents a breakthrough in molecular research, offering unparalleled specificity, sensitivity, and stability. Its multifaceted applications in research and therapeutic development make it an invaluable asset for scientists and clinicians alike. Embrace the future of molecular research with the EPHA1 Monoclonal Antibody and unlock new frontiers in scientific discovery.